The Journal of Viral Entry is an independent journal published by Remedica Medical Education and Publishing Ltd. Editorial control is the sole responsibility of the Editors-in-Chief and the Editors. Before publication, all material submitted to the journal is subjected to rigorous review by the Editors-in-Chief, Editors, and/or independent reviewers for suitability of scientific content, scientific accuracy, scientific quality, and conflict of interest.
Aims and Scope
The Journal of Viral Entry is designed to bring a critical analysis of the world antiviral medicine literature, written by clinicians, for clinicians, to an international, multidisciplinary audience. Our mission is to promote better understanding of antiviral medicine across the global healthcare system by providing an active forum for the discussion of clinical and healthcare policy issues.
These major review articles are chosen to reflect topical clinical and healthcare policy issues in antiviral medicine. All contributions undergo a strict editorial review process.
The most important papers from the best of the international literature on antiviral medicine are systematically selected by an internationally recognized panel of experts. The Editors then prepare a concise and critical analysis of each paper, and, most importantly, place the findings into clinical context.
© 2005–2010 Remedica Medical Education and Publishing.
Any queries regarding the content of the journal should be addressed to:
Remedica Medical Education and
Publishing Ltd., Commonwealth House, 1 New Oxford Street, London, WC1A 1NU, UK.
Editorial Manager: Emma Beagley
Editorial Director: Scott Millar
Design and Artwork: AS&K Skylight Creative Services
Publishers: Ian Ackland-Snow, Simon Kirsch
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the copyright owners.
ISSN 2040-3925 (Print)